Clinical Trial Update: A United States Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression [Phase 3]

View source ↗

Summary

This document notes the completion of a United States extension study of Corlux for recurrent psychotic symptoms in major depressive disorder with psychotic fea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder with Psychotic Features

Drugs mentioned

• CORLUX (mifepristone)

Snippet

Sponsor: Corcept Therapeutics | Conditions: Depressive Disorder, Major | Phase 3 | Status: COMPLETED